MedPath

Omega-3 fatty acids

Generic Name
Omega-3 fatty acids
Brand Names
Animi-3 With Vitamin D, Vitafol-one
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
329042-31-1
Unique Ingredient Identifier
71M78END5S
Background

Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain. The three types of omega-3 fatty acids involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) (both commonly found in fish oil that originally come from microalgae that is further consumed by phytoplankton, a source of diet for fish). Omega-3 fatty acids play a critical role in metabolism and cellular function and they are available as daily supplements. On September 8, 2004, the U.S. Food and Drug Administration gave "qualified health claim" status to EPA and DHA omega-3 fatty acids. Therapeutic products containing omega-3 fatty acid and its derivatives for treatment of hypertriglyceridemia include Lovaza, Omtryg, Epanova, and Vascepa.

Indication

Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia.

Associated Conditions
-
Associated Therapies
Nutritional supplementation, Parenteral Nutrition

dsm-firmenich launches DHA rich omega-3 ingredient, life'sDHA B54-0100

dsm-firmenich launches life'sDHA B54-0100, its most potent DHA oil, offering 620mg of omega-3s per serving, derived from algae for sustainability. The company also introduces life'sOMEGA O3020 to North America, an algal omega-3 with a standard EPA to DHA ratio, and plans to launch high-potency EPA ingredients in 2025.
nhlbi.nih.gov
·

Omega-3s for heart health? Exploring potential benefits and risks

Fish oil omega-3 supplements' effectiveness in heart disease prevention is uncertain, with mixed clinical trial results and potential risks. VITAL trial showed no overall CVD risk reduction but significant benefits for low fish consumers, high-risk individuals, and African Americans. REDUCE-IT trial found icosapent ethyl reduced CVD risk by 25% in high-risk patients. Research continues on optimal omega-3 forms and mechanisms, with caution advised on high-dose supplement use.
stocktitan.net
·

Nitches, Inc. Launches New Vertical With American-Made Bioceutical Company, Introducing ...

Nitches, Inc. launches InTheZone Labs, partnering with an American bioceutical and nutraceutical manufacturer to introduce products enhancing mental focus, vitality, and cognitive development. The flagship products include InTheZone Focused, Passion, and Focused Youth. A Phase One Study led by medical experts and former NFL athletes aims to validate their effectiveness. Nitches targets the projected $650 billion nutraceutical and bioceutical market by 2027, building a distribution and affiliate network.
foodforthebrain.org
·

Alzheimer's, Omega 3 & B Vitamins | Food for the Brain

Omega-3 and B vitamins may synergistically prevent dementia. Omega-3, especially DHA, supports brain health, while B vitamins lower homocysteine, reducing Alzheimer's risk. Studies suggest their combined intake enhances cognitive protection, emphasizing the importance of diet in dementia prevention.
© Copyright 2025. All Rights Reserved by MedPath